Atlas Trials

A Dose Escalation Study of OMP-18R5 in Subjects With Solid Tumors

Clinical trial NCT01345201 · COMPLETED

Trial details

NCT number
NCT01345201
Sponsor
OncoMed Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Solid Tumors
Start date
2011-05-01
Primary completion
2014-05-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.